Two non-drug, device approaches to tackling the opioid crisis
Companies are developing non-drug approaches to tackling the prescription opioid crisis and stand to receive support from the likes of the NIH and the FDA.
Companies are developing non-drug approaches to tackling the prescription opioid crisis and stand to receive support from the likes of the NIH and the FDA.
Flex, a global electronics contract manufacturer, is reshaping itself to grow its $2 billion healthcare business and believes its take on the future will help traditional medtech companies fare better.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.